hat
Malgre ke yo trè menm jan an nan estrikti, methyltrienolone se trè diferan nan efè nan tranbolon. Li te gen yon rapò anabolizan anrojenik nan 12000/6000 an konparezon ak methyl-testostewòn, ki fè li pètèt esteroyid ki pi pisan nan egzistans. Methyltrienolone kapab tou pi presyon lyan reseptè Androjen nan tout estewoyid. Methyltrienolone mande dòz ti piti yo wè gwo pwogrè nan gwosè ak fòs. Methyltrienolone pa konvèti nan estwojèn, men li gen aktivite progestational ki ka ogmante efè estwojèn. Sa a ka konsidere kòm yon "sèk" konpoze ki pa pral lakòz anpil si anyen pou lar (anba po a) dlo retansyon.
eng
Although they are very similar in structure, methyltrienolone is very different in effect from trenbolone. It has an anabolic to androgenic ratio of 12000/6000 in comparison to methyl-testosterone, making it possibly the most potent steroid in existence. Methyltrienolone may also be the strongest androgen receptor binder of all steroids. Methyltrienolone required very small doses to see big gains in size and strength. Methyltrienolone does not convert to estrogen, but it does have progestational activity which may increase the effects of estrogen. This can be considered a “dry” compound that will not cause much if anything for subcutaneous (under the skin) water retention.